The Gut Microbiome in Parkinson's Disease: A Longitudinal Study of the Impacts on Disease Progression and the Use of Device-Assisted Therapies/Experiment 9/Signature 2
From BugSigDB
< The Gut Microbiome in Parkinson's Disease: A Longitudinal Study of the Impacts on Disease Progression and the Use of Device-Assisted Therapies | The Gut Microbiome in Parkinson's Disease: A Longitudinal Study of the Impacts on Disease Progression and the Use of Device-Assisted Therapies/Experiment 9
Needs review
Source: Figure 7
Description: The most differentially abundant taxa after the initiation of LCIG therapy at the family level over the (t = 0 to t = 6) interval.
Abundance in Group 1: decreased abundance in Deep Brain Stimulation DAT patients (t = 0 to t = 6)
| NCBI | Quality Control | Links |
|---|---|---|
| Acetanaerobacterium | ||
| Eggerthella | ||
| Gordonibacter | ||
| Hespellia | ||
| Holdemania |
Revision editor(s): Bolanle, Fiddyhamma
